Skip to main content
OpenTrials
Completed

NCT Number: NCT00221260

Perioperative Epidural Trial (POET) Pilot Study

To investigate if the use of perioperative neuraxial blockade reduces post-operative mortality and cardiorespiratory events compared to intraoperative general anesthesia AND postoperative IV narcotic analgesia. This is a feasibility study to determine if recruitment and execution of the protocol could be done in a timely manner in a much larger trial

Completed

Looking for future studies?

Notify Me

Key information

Age range

45 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Vancouver General Hospital, Clinical Health Research Unit

Vancouver, British Columbia, V5Z 1L8, Canada

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Subjects at high risk of cardio-respiratory complications post operatively.

Exclusion criteria

Contraindication to epidural anesthesia

Treatment and study plan

Anesthesia

Procedure

Intraoperative general anesthesia AND postoperative IV narcotic analgesia.

Primary outcomes

  1. Combined mortality, MI, cardiac arrest, post operative pneumonia , and respiratory failure

Secondary outcomes

  1. DVT, pulmonary embolism, TIA, CVA, CHF, clinically significant bradycardia/hypotension

Sponsors and collaborators

Lead sponsor

University of British Columbia

Other

Collaborators

  • Canadian Institutes of Health Research (CIHR)

Registry information

Important dates

Study start
2005
Primary completion
2008
Study completion
2008
First posted
Sep 22, 2005
Registry last updated
Sep 25, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.